 | • レポートコード：GIR-105X02943 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ブデソニド吸入器のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ブデソニド吸入器の種類別市場規模（ドライパウダー、サスペンション、スプレー）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ブデソニド吸入器の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：AstraZeneca、Cosmo Pharmaceuticals、Teva Pharmaceutical、Novartis、Mylan、Pfizer、Dr. Falk Pharma、Chiesi Farmaceutici、Orion Corporation、Cipla Limited、Bausch Health Companies、Takeda Pharmaceutical、Lupin Limited、Synmosa Biopharma Corporation、Lunan Better Pharmaceutical、Shanghai Sine Pharmaceutical Laboratories ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ドライパウダー、サスペンション、スプレー ・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局 ・ブデソニド吸入器の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ブデソニド吸入器のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ブデソニド吸入器のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ブデソニド吸入器の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ブデソニド吸入器の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Budesonide Inhaler market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Budesonide Inhaler size is estimated to be xx million in 2020 from USD 4595.8 million in 2019, with a change of XX% between 2019 and 2020. The global Budesonide Inhaler market size is expected to grow at a CAGR of 3.1% for the next five years.
Market segmentation
Budesonide Inhaler market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Dry Powder
Suspension
Sprays
Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The key market players for global Budesonide Inhaler market are listed below:
AstraZeneca
Cosmo Pharmaceuticals
Teva Pharmaceutical
Novartis
Mylan
Pfizer
Dr. Falk Pharma
Chiesi Farmaceutici
Orion Corporation
Cipla Limited
Bausch Health Companies
Takeda Pharmaceutical
Lupin Limited
Synmosa Biopharma Corporation
Lunan Better Pharmaceutical
Shanghai Sine Pharmaceutical Laboratories
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Budesonide Inhaler Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Budesonide Inhaler Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Dry Powder
1.2.3 Suspension
1.2.4 Sprays
1.3 Market Analysis by Application
1.3.1 Overview: Global Budesonide Inhaler Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Budesonide Inhaler Market Size & Forecast
1.4.1 Global Budesonide Inhaler Sales in Value (2016-2026))
1.4.2 Global Budesonide Inhaler Sales in Volume (2016-2026)
1.4.3 Global Budesonide Inhaler Price by Type (2016-2026) & (USD/Unit)
1.5 Global Budesonide Inhaler Production Capacity Analysis
1.5.1 Global Budesonide Inhaler Total Production Capacity (2016-2026)
1.5.2 Global Budesonide Inhaler Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Budesonide Inhaler Market Drivers
1.6.2 Budesonide Inhaler Market Restraints
1.6.3 Budesonide Inhaler Trends Analysis
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Budesonide Inhaler Product and Services
2.1.4 AstraZeneca Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Cosmo Pharmaceuticals
2.2.1 Cosmo Pharmaceuticals Details
2.2.2 Cosmo Pharmaceuticals Major Business
2.2.3 Cosmo Pharmaceuticals Budesonide Inhaler Product and Services
2.2.4 Cosmo Pharmaceuticals Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Teva Pharmaceutical
2.3.1 Teva Pharmaceutical Details
2.3.2 Teva Pharmaceutical Major Business
2.3.3 Teva Pharmaceutical Budesonide Inhaler Product and Services
2.3.4 Teva Pharmaceutical Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Budesonide Inhaler Product and Services
2.4.4 Novartis Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business
2.5.3 Mylan Budesonide Inhaler Product and Services
2.5.4 Mylan Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Budesonide Inhaler Product and Services
2.6.4 Pfizer Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Dr. Falk Pharma
2.7.1 Dr. Falk Pharma Details
2.7.2 Dr. Falk Pharma Major Business
2.7.3 Dr. Falk Pharma Budesonide Inhaler Product and Services
2.7.4 Dr. Falk Pharma Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Chiesi Farmaceutici
2.8.1 Chiesi Farmaceutici Details
2.8.2 Chiesi Farmaceutici Major Business
2.8.3 Chiesi Farmaceutici Budesonide Inhaler Product and Services
2.8.4 Chiesi Farmaceutici Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Orion Corporation
2.9.1 Orion Corporation Details
2.9.2 Orion Corporation Major Business
2.9.3 Orion Corporation Budesonide Inhaler Product and Services
2.9.4 Orion Corporation Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Cipla Limited
2.10.1 Cipla Limited Details
2.10.2 Cipla Limited Major Business
2.10.3 Cipla Limited Budesonide Inhaler Product and Services
2.10.4 Cipla Limited Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Bausch Health Companies
2.11.1 Bausch Health Companies Details
2.11.2 Bausch Health Companies Major Business
2.11.3 Bausch Health Companies Budesonide Inhaler Product and Services
2.11.4 Bausch Health Companies Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Takeda Pharmaceutical
2.12.1 Takeda Pharmaceutical Details
2.12.2 Takeda Pharmaceutical Major Business
2.12.3 Takeda Pharmaceutical Budesonide Inhaler Product and Services
2.12.4 Takeda Pharmaceutical Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Lupin Limited
2.13.1 Lupin Limited Details
2.13.2 Lupin Limited Major Business
2.13.3 Lupin Limited Budesonide Inhaler Product and Services
2.13.4 Lupin Limited Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Synmosa Biopharma Corporation
2.14.1 Synmosa Biopharma Corporation Details
2.14.2 Synmosa Biopharma Corporation Major Business
2.14.3 Synmosa Biopharma Corporation Budesonide Inhaler Product and Services
2.14.4 Synmosa Biopharma Corporation Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Lunan Better Pharmaceutical
2.15.1 Lunan Better Pharmaceutical Details
2.15.2 Lunan Better Pharmaceutical Major Business
2.15.3 Lunan Better Pharmaceutical Budesonide Inhaler Product and Services
2.15.4 Lunan Better Pharmaceutical Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 Shanghai Sine Pharmaceutical Laboratories
2.16.1 Shanghai Sine Pharmaceutical Laboratories Details
2.16.2 Shanghai Sine Pharmaceutical Laboratories Major Business
2.16.3 Shanghai Sine Pharmaceutical Laboratories Budesonide Inhaler Product and Services
2.16.4 Shanghai Sine Pharmaceutical Laboratories Budesonide Inhaler Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Budesonide Inhaler Sales by Manufacturer
3.1 Global Budesonide Inhaler Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Budesonide Inhaler Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Budesonide Inhaler
3.4 Market Concentration Rate
3.4.1 Top 3 Budesonide Inhaler Manufacturer Market Share
3.4.2 Top 6 Budesonide Inhaler Manufacturer Market Share
3.5 Global Budesonide Inhaler Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Budesonide Inhaler Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Budesonide Inhaler Market Size by Region
4.1.1 Global Budesonide Inhaler Sales in Volume by Region (2016-2026)
4.1.2 Global Budesonide Inhaler Revenue by Region (2016-2026)
4.2 North America Budesonide Inhaler Revenue (2016-2026)
4.3 Europe Budesonide Inhaler Revenue (2016-2026)
4.4 Asia-Pacific Budesonide Inhaler Revenue (2016-2026)
4.5 South America Budesonide Inhaler Revenue (2016-2026)
4.6 Middle East and Africa Budesonide Inhaler Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Budesonide Inhaler Sales in Volume by Type (2016-2026)
5.2 Global Budesonide Inhaler Revenue by Type (2016-2026)
5.3 Global Budesonide Inhaler Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Budesonide Inhaler Sales in Volume by Application (2016-2026)
6.2 Global Budesonide Inhaler Revenue by Application (2016-2026)
6.3 Global Budesonide Inhaler Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Budesonide Inhaler Sales by Type (2016-2026)
7.2 North America Budesonide Inhaler Sales by Application (2016-2026)
7.3 North America Budesonide Inhaler Market Size by Country
7.3.1 North America Budesonide Inhaler Sales in Volume by Country (2016-2026)
7.3.2 North America Budesonide Inhaler Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Budesonide Inhaler Sales by Type (2016-2026)
8.2 Europe Budesonide Inhaler Sales by Application (2016-2026)
8.3 Europe Budesonide Inhaler Market Size by Country
8.3.1 Europe Budesonide Inhaler Sales in Volume by Country (2016-2026)
8.3.2 Europe Budesonide Inhaler Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Budesonide Inhaler Sales by Type (2016-2026)
9.2 Asia-Pacific Budesonide Inhaler Sales by Application (2016-2026)
9.3 Asia-Pacific Budesonide Inhaler Market Size by Region
9.3.1 Asia-Pacific Budesonide Inhaler Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Budesonide Inhaler Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Budesonide Inhaler Sales by Type (2016-2026)
10.2 South America Budesonide Inhaler Sales by Application (2016-2026)
10.3 South America Budesonide Inhaler Market Size by Country
10.3.1 South America Budesonide Inhaler Sales in Volume by Country (2016-2026)
10.3.2 South America Budesonide Inhaler Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Budesonide Inhaler Sales by Type (2016-2026)
11.2 Middle East & Africa Budesonide Inhaler Sales by Application (2016-2026)
11.3 Middle East & Africa Budesonide Inhaler Market Size by Country
11.3.1 Middle East & Africa Budesonide Inhaler Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Budesonide Inhaler Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Budesonide Inhaler Typical Distributors
12.3 Budesonide Inhaler Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Budesonide Inhaler Revenue by Type, (USD Million), 2021-2026
Table 2. Global Budesonide Inhaler Revenue by Application, (USD Million), 2021-2026
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Budesonide Inhaler Product and Services
Table 6. AstraZeneca Budesonide Inhaler Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Cosmo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Cosmo Pharmaceuticals Major Business
Table 9. Cosmo Pharmaceuticals Budesonide Inhaler Product and Services
Table 10. Cosmo Pharmaceuticals Budesonide Inhaler Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 12. Teva Pharmaceutical Major Business
Table 13. Teva Pharmaceutical Budesonide Inhaler Product and Services
Table 14. Teva Pharmaceutical Budesonide Inhaler Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Novartis Basic Information, Manufacturing Base and Competitors
Table 16. Novartis Major Business
Table 17. Novartis Budesonide Inhaler Product and Services
Table 18. Novartis Budesonide Inhaler Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Mylan Basic Information, Manufacturing Base and Competitors
Table 20. Mylan Major Business
Table 21. Mylan Budesonide Inhaler Product and Services
Table 22. Mylan Budesonide Inhaler Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Budesonide Inhaler Product and Services
Table 26. Pfizer Budesonide Inhaler Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Dr. Falk Pharma Basic Information, Manufacturing Base and Competitors
Table 28. Dr. Falk Pharma Major Business
Table 29. Dr. Falk Pharma Budesonide Inhaler Product and Services
Table 30. Dr. Falk Pharma Budesonide Inhaler Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Chiesi Farmaceutici Basic Information, Manufacturing Base and Competitors
Table 32. Chiesi Farmaceutici Major Business
Table 33. Chiesi Farmaceutici Budesonide Inhaler Product and Services
Table 34. Chiesi Farmaceutici Budesonide Inhaler Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Orion Corporation Basic Information, Manufacturing Base and Competitors
Table 36. Orion Corporation Major Business
Table 37. Orion Corporation Budesonide Inhaler Product and Services
Table 38. Orion Corporation Budesonide Inhaler Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Cipla Limited Basic Information, Manufacturing Base and Competitors
Table 40. Cipla Limited Major Business
Table 41. Cipla Limited Budesonide Inhaler Product and Services
Table 42. Cipla Limited Budesonide Inhaler Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Bausch Health Companies Basic Information, Manufacturing Base and Competitors
Table 44. Bausch Health Companies Major Business
Table 45. Bausch Health Companies Budesonide Inhaler Product and Services
Table 46. Bausch Health Companies Budesonide Inhaler Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Takeda Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 48. Takeda Pharmaceutical Major Business
Table 49. Takeda Pharmaceutical Budesonide Inhaler Product and Services
Table 50. Takeda Pharmaceutical Budesonide Inhaler Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Lupin Limited Basic Information, Manufacturing Base and Competitors
Table 52. Lupin Limited Major Business
Table 53. Lupin Limited Budesonide Inhaler Product and Services
Table 54. Lupin Limited Budesonide Inhaler Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Synmosa Biopharma Corporation Basic Information, Manufacturing Base and Competitors
Table 56. Synmosa Biopharma Corporation Major Business
Table 57. Synmosa Biopharma Corporation Budesonide Inhaler Product and Services
Table 58. Synmosa Biopharma Corporation Budesonide Inhaler Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Lunan Better Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 60. Lunan Better Pharmaceutical Major Business
Table 61. Lunan Better Pharmaceutical Budesonide Inhaler Product and Services
Table 62. Lunan Better Pharmaceutical Budesonide Inhaler Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Shanghai Sine Pharmaceutical Laboratories Basic Information, Manufacturing Base and Competitors
Table 64. Shanghai Sine Pharmaceutical Laboratories Major Business
Table 65. Shanghai Sine Pharmaceutical Laboratories Budesonide Inhaler Product and Services
Table 66. Shanghai Sine Pharmaceutical Laboratories Budesonide Inhaler Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Global Budesonide Inhaler Sales by Manufacturer (2019-2021e) & (K Units)
Table 68. Global Budesonide Inhaler Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 69. Market Position of Manufacturers in Budesonide Inhaler, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 70. Global Budesonide Inhaler Production Capacity by Company, (K Units): 2020 VS 2021
Table 71. Head Office and Budesonide Inhaler Production Site of Key Manufacturer
Table 72. Global Budesonide Inhaler Sales by Region (2016-2021e) & (K Units)
Table 73. Global Budesonide Inhaler Sales by Region (2021-2026) & (K Units)
Table 74. Global Budesonide Inhaler Revenue by Region (2016-2021e) & (USD Million)
Table 75. Global Budesonide Inhaler Revenue by Region (2021-2026) & (USD Million)
Table 76. Global Budesonide Inhaler Sales by Type (2016-2021e) & (K Units)
Table 77. Global Budesonide Inhaler Sales by Type (2021-2026) & (K Units)
Table 78. Global Budesonide Inhaler Revenue by Type (2016-2021e) & (USD Million)
Table 79. Global Budesonide Inhaler Revenue by Type (2021-2026) & (USD Million)
Table 80. Global Budesonide Inhaler Price by Type (2016-2021e) & (USD/Unit)
Table 81. Global Budesonide Inhaler Price by Type (2021-2026) & (USD/Unit)
Table 82. Global Budesonide Inhaler Sales by Application (2016-2021e) & (K Units)
Table 83. Global Budesonide Inhaler Sales by Application (2021-2026) & (K Units)
Table 84. Global Budesonide Inhaler Revenue by Application (2016-2021e) & (USD Million)
Table 85. Global Budesonide Inhaler Revenue by Application (2021-2026) & (USD Million)
Table 86. Global Budesonide Inhaler Price by Application (2016-2021e) & (USD/Unit)
Table 87. Global Budesonide Inhaler Price by Application (2021-2026) & (USD/Unit)
Table 88. North America Budesonide Inhaler Sales by Country (2016-2021e) & (K Units)
Table 89. North America Budesonide Inhaler Sales by Country (2021-2026) & (K Units)
Table 90. North America Budesonide Inhaler Revenue by Country (2016-2021e) & (USD Million)
Table 91. North America Budesonide Inhaler Revenue by Country (2021-2026) & (USD Million)
Table 92. North America Budesonide Inhaler Sales by Type (2016-2021e) & (K Units)
Table 93. North America Budesonide Inhaler Sales by Type (2021-2026) & (K Units)
Table 94. North America Budesonide Inhaler Sales by Application (2016-2021e) & (K Units)
Table 95. North America Budesonide Inhaler Sales by Application (2021-2026) & (K Units)
Table 96. Europe Budesonide Inhaler Sales by Country (2016-2021e) & (K Units)
Table 97. Europe Budesonide Inhaler Sales by Country (2021-2026) & (K Units)
Table 98. Europe Budesonide Inhaler Revenue by Country (2016-2021e) & (USD Million)
Table 99. Europe Budesonide Inhaler Revenue by Country (2021-2026) & (USD Million)
Table 100. Europe Budesonide Inhaler Sales by Type (2016-2021e) & (K Units)
Table 101. Europe Budesonide Inhaler Sales by Type (2021-2026) & (K Units)
Table 102. Europe Budesonide Inhaler Sales by Application (2016-2021e) & (K Units)
Table 103. Europe Budesonide Inhaler Sales by Application (2021-2026) & (K Units)
Table 104. Asia-Pacific Budesonide Inhaler Sales by Region (2016-2021e) & (K Units)
Table 105. Asia-Pacific Budesonide Inhaler Sales by Region (2021-2026) & (K Units)
Table 106. Asia-Pacific Budesonide Inhaler Revenue by Region (2016-2021e) & (USD Million)
Table 107. Asia-Pacific Budesonide Inhaler Revenue by Region (2021-2026) & (USD Million)
Table 108. Asia-Pacific Budesonide Inhaler Sales by Type (2016-2021e) & (K Units)
Table 109. Asia-Pacific Budesonide Inhaler Sales by Type (2021-2026) & (K Units)
Table 110. Asia-Pacific Budesonide Inhaler Sales by Application (2016-2021e) & (K Units)
Table 111. Asia-Pacific Budesonide Inhaler Sales by Application (2021-2026) & (K Units)
Table 112. South America Budesonide Inhaler Sales by Country (2016-2021e) & (K Units)
Table 113. South America Budesonide Inhaler Sales by Country (2021-2026) & (K Units)
Table 114. South America Budesonide Inhaler Revenue by Country (2016-2021e) & (USD Million)
Table 115. South America Budesonide Inhaler Revenue by Country (2021-2026) & (USD Million)
Table 116. South America Budesonide Inhaler Sales by Type (2016-2021e) & (K Units)
Table 117. South America Budesonide Inhaler Sales by Type (2021-2026) & (K Units)
Table 118. South America Budesonide Inhaler Sales by Application (2016-2021e) & (K Units)
Table 119. South America Budesonide Inhaler Sales by Application (2021-2026) & (K Units)
Table 120. Middle East & Africa Budesonide Inhaler Sales by Country (2016-2021e) & (K Units)
Table 121. Middle East & Africa Budesonide Inhaler Sales by Country (2021-2026) & (K Units)
Table 122. Middle East & Africa Budesonide Inhaler Revenue by Country (2016-2021e) & (USD Million)
Table 123. Middle East & Africa Budesonide Inhaler Revenue by Country (2021-2026) & (USD Million)
Table 124. Middle East & Africa Budesonide Inhaler Sales by Type (2016-2021e) & (K Units)
Table 125. Middle East & Africa Budesonide Inhaler Sales by Type (2021-2026) & (K Units)
Table 126. Middle East & Africa Budesonide Inhaler Sales by Application (2016-2021e) & (K Units)
Table 127. Middle East & Africa Budesonide Inhaler Sales by Application (2021-2026) & (K Units)
Table 128. Direct Channel Pros & Cons
Table 129. Indirect Channel Pros & Cons
Table 130. Budesonide Inhaler Typical Distributors
Table 131. Budesonide Inhaler Typical Customers
List of Figures
Figure 1. Budesonide Inhaler Picture
Figure 2. Global Budesonide Inhaler Sales Market Share by Type in 2020
Figure 3. Dry Powder
Figure 4. Suspension
Figure 5. Sprays
Figure 6. Global Budesonide Inhaler Sales Market Share by Application in 2020
Figure 7. Hospital Pharmacies
Figure 8. Retail Pharmacies
Figure 9. Online Pharmacies
Figure 10. Global Budesonide Inhaler Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Budesonide Inhaler Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Budesonide Inhaler Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Budesonide Inhaler Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Budesonide Inhaler Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Budesonide Inhaler Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Budesonide Inhaler Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Budesonide Inhaler Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Budesonide Inhaler Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Budesonide Inhaler Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Budesonide Inhaler Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Budesonide Inhaler Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Budesonide Inhaler Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Budesonide Inhaler Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Budesonide Inhaler Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Budesonide Inhaler Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Budesonide Inhaler Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Budesonide Inhaler Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Budesonide Inhaler Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Budesonide Inhaler Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Budesonide Inhaler Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Budesonide Inhaler Sales (2016-2026) & (K Units)
Figure 32. Global Budesonide Inhaler Production Capacity (2016-2026) & (K Units)
Figure 33. Global Budesonide Inhaler Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Budesonide Inhaler Market Drivers
Figure 35. Budesonide Inhaler Market Restraints
Figure 36. Budesonide Inhaler Market Trends
Figure 37. Global Budesonide Inhaler Sales Market Share by Manufacturer in 2020
Figure 38. Global Budesonide Inhaler Revenue Market Share by Manufacturer in 2020
Figure 39. Budesonide Inhaler Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Budesonide Inhaler Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Budesonide Inhaler Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Budesonide Inhaler Sales Market Share by Region (2016-2026)
Figure 43. Global Budesonide Inhaler Revenue Market Share by Region (2016-2026)
Figure 44. North America Budesonide Inhaler Revenue (2016-2026) & (USD Million)
Figure 45. Europe Budesonide Inhaler Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Budesonide Inhaler Revenue (2016-2026) & (USD Million)
Figure 47. South America Budesonide Inhaler Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Budesonide Inhaler Revenue (2016-2026) & (USD Million)
Figure 49. Global Budesonide Inhaler Sales Market Share by Type (2016-2026)
Figure 50. Global Budesonide Inhaler Revenue Market Share by Type (2016-2026)
Figure 51. Global Budesonide Inhaler Price by Type (2016-2026) & (USD/Unit)
Figure 52. Global Budesonide Inhaler Sales Market Share by Application (2016-2026)
Figure 53. Global Budesonide Inhaler Revenue Market Share by Application (2016-2026)
Figure 54. Global Budesonide Inhaler Price by Application (2016-2026) & (USD/Unit)
Figure 55. North America Budesonide Inhaler Sales Market Share by Country (2016-2026)
Figure 56. North America Budesonide Inhaler Revenue Market Share by Country (2016-2026)
Figure 57. North America Budesonide Inhaler Sales Market Share by Type (2016-2026)
Figure 58. North America Budesonide Inhaler Sales Market Share by Application (2016-2026)
Figure 59. Europe Budesonide Inhaler Sales Market Share by Country (2016-2026)
Figure 60. Europe Budesonide Inhaler Revenue Market Share by Country (2016-2026)
Figure 61. Europe Budesonide Inhaler Sales Market Share by Type (2016-2026)
Figure 62. Europe Budesonide Inhaler Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Budesonide Inhaler Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Budesonide Inhaler Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Budesonide Inhaler Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Budesonide Inhaler Sales Market Share by Application (2016-2026)
Figure 67. South America Budesonide Inhaler Sales Market Share by Country (2016-2026)
Figure 68. South America Budesonide Inhaler Revenue Market Share by Country (2016-2026)
Figure 69. South America Budesonide Inhaler Sales Market Share by Type (2016-2026)
Figure 70. South America Budesonide Inhaler Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Budesonide Inhaler Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Budesonide Inhaler Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Budesonide Inhaler Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Budesonide Inhaler Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
ブデソニドの世界市場2018-2025 This study researches the market size of Budesonide, presents the global Budesonide sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.This report focuses on the key data information of Budesonide in key regions like North Am…- スマート吸入器技術の世界市場予測 2023年：メーカー別、地域別、種類・用途別 The smart inhaler technology uses sensors and requires a smartphone or a computer-based app, which can be integrated into any metered-dose inhaler (MDI) or dry-powder inhaler (DPI) inhaler to convert it into a smart inhaler. The sensors used in smart inhalers can be connected to the user's smartphon…
- 世界の吸入器デバイス市場 2021：企業別、地域別、種類・用途別 The Inhaler Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, re…
- 吸入コルチコステロイドの世界市場2018-2025 Asthma is a disease of the entire respiratory tract, including large, intermediate and small airways. Asthma led to inflammation and obstruction of respiratory tract. Patients have various treatment options for asthma, particularly for young and elderly patients. Hence this has led to significant in…
- コルチコステロイドスプレー式点鼻薬の世界市場2018-2025 In 2018, the global Corticosteroid Nasal Spray market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Corticosteroid Nasal Spra…